Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardiorespiratory Fitness in Coronary Artery Disease

Not Applicable

Not yet recruiting

• Conditions: Coronary Arterial Disease (CAD)

• Registration Number: NCT06919237
• Lead Sponsor: Faculdade de Motricidade Humana

Brief Summary

Coronary artery disease (CAD) is associated with autonomic dysfunction and is characterized by reduced heart rate variability (HRV) and impaired heart rate recovery. Regular exercise improves cardiovascular outcomes in CAD, with high-intensity interval training (HIIT) showing superior benefits compared to moderate-intensity continuous training (MICT). However, the full potential of exercise is not used in the clinical context since some of the training principles are neglected, contributing to a high number of exercise non-responders. HRV-guided training has been identified as an alternative prescription technique for cardiovascular endurance exercise and has contributed to greater improvements compared to standard prescriptions. Thus, this study aims to assess the chronic effects of exercise on cardiovagal modulation, baroreflex sensitivity, arterial stiffness, and cardiorespiratory fitness in patients with CAD, specifically determining whether heart rate variability-guided training yields different outcomes compared to a traditional prescription in a 12-week exercise intervention.

A total of 48 participants, will be recruited and randomized into one of 3 groups: high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), and HRV-guided training. The intervention will consist of 12 weeks of supervised exercise, with 3 weekly sessions. Participants in the HRV-guided training group will have their exercise intensity adjusted based on their individual HRV profiles. Moderate- or high-intensity sessions are prescribed when the 7-day rolling average of LnRMSSD remains within the smallest worthwhile change (SWC). If it falls outside the SWC, low-intensity sessions or rest are recommended. In the HIIT group, sessions will consist of 4 bouts of 2 minutes at 80-90% HRR during the first 4 weeks, increasing to 6 bouts of 2 minutes at the same intensity in weeks 5-8, and progressing to 6 bouts of 2 minutes at 90% HRR in the final 4 weeks. In the MICT group, participants will perform continuous sessions starting with 2x10 minutes at 50-60% HRR in the first 4 weeks, progressing to 2x12 minutes at the same intensity in weeks 5-8, and increasing to 2x15 minutes at 60-70% HRR in the final phase. Cardiovagal modulation, cardiorespiratory fitness, BRS, and AS will be assessed at the baseline and after the 12 weeks of intervention.

Most cardiac rehabilitation programs use the "one-size-fits-all" approach, which is a limitation of the literature, leading to a large number of exercise nonresponders to changes in cardiorespiratory fitness. HRV-guided training seems to be a more individualized method of aerobic prescription and may lead to greater improvements in cardiorespiratory fitness and in cardiovagal modulation. This study will contribute to generate evidence regarding aerobic exercise prescription in cardiac rehabilitation.

Detailed Description

Background

Coronary artery disease (CAD) is characterized by the inability to adequately supply blood and oxygen to the heart, often resulting from the formation of atherosclerotic plaques within the arterial lumen. This inflammatory, multifactorial condition can impair the autonomic nervous system (ANS), disrupting the balance between the sympathetic and parasympathetic pathways and leading to autonomic dysfunction. Key indicators of this dysfunction include reduced heart rate variability (HRV) and delayed heart rate recovery, both of which signify heightened sympathetic activity and diminished parasympathetic activity. These changes predict worse cardiovascular outcomes in CAD patients, as the ANS compensates for myocardial ischemia and hypoxia by increasing sympathetic drive and reducing vagal activity to preserve cardiac contractility and output. This imbalance triggers a cascade of neurohumoral alterations affecting the cardiovascular, peripheral vascular, and renal systems, further exacerbating disease progression.

Regular exercise is known to play an important role in the prevention, management, and treatment of CAD, mainly through the preservation of endothelial function but also through the improvement of cardiovagal modulation and neurocardiovascular stress reactivity and by the increase in cardiorespiratory fitness. Patients with stable CAD should undergo a cardiac rehabilitation program to fulfill exercise guidelines. Protocols may vary in mode, intensity, frequency, and duration, whereas the most recommended types of exercise are walking and cycling, with intensities between 40-80% of VO2peak associated with increases in exercise capacity by 11-36%. Recent studies demonstrated that high-intensity interval training (HIIT) compared with moderate-intensity continuous training (MICT) promotes higher adaptation in VO2max and in post-exercise heart rate recovery, HIIT has also demonstrated to contribute to the restoration of endothelial function and autonomic balance, inducing reverse cardiac remodeling and increasing left ventricle morphology and function. However, MICT demonstrates higher adherence because it is a safer and more effective approach. Nevertheless, despite the known non-pharmacological benefits of exercise, recent studies demonstrate that more than 15% of the patients with CAD are exercise non-responders to increases in VO2max , i.e., an increase of 3.5 ml/kg/min in VO2max, which has been associated with a 10% decrease in all-cause of mortality and cardiovascular mortality, however the greater the increases in VO2max the greater the reduction in the risk.

Exercise individualization is increasing among apparently healthy populations due to the ease of the use of cellphone applications. Recently, HRV-guided training has been identified as an alternative prescription technique for cardiovascular endurance exercise prescription, this prescription technique demonstrated to contribute to greater improvements in endurance athletes. HRV-guided training concerns to exercise prescribed based on daily changes in HRV, depending on thresholds constructed at the individual level. After an initial characterization period, where the HRV after waking up is measured, the individual HRV profile is defined. Then, considering the resting values of HRV, exercise intensity will be determined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (+), high-intensity or moderate-intensity training sessions is prescribed, and if LnRMSSD7day-roll-avg fell outside SWC (-), low intensity or rest is prescribed. This prescription technique leads to different workloads from the predefined training programs.

To the best of our knowledge, no study has yet compared the chronic effects of two different exercise protocols on cardiovagal modulation, and cardiorespiratory fitness in patients with CAD. Thus, this research aims to compare the chronic adaptations on cardiorespiratory fitness, cardiovagal modulation, baroreflex sensitivity (BRS), and arterial stiffness (AS) of two different techniques of exercise prescription (traditional vs individualized) and two training methods (HIIT vs MICT) in patients with CAD. We hypothesize that exercise individualization will promote higher adaptations in cardiovagal modulation, cardiorespiratory fitness, BRS and AS in patients with CAD, compared with traditional prescription.

Methods

Study design This longitudinal randomized trial will consist of comparing the effects of different exercise prescription techniques and different methods of exercise prescription (traditional MICT, traditional HIIT, and HRV-guided training) would exhibit differences in chronic adaptations in cardiorespiratory fitness, cardiovagal modulation, and BRS in patients with CAD. The study will consist of 12 weeks of supervised exercise with 3 sessions per week. This study protocol was submitted to the Faculty of Human Kinetics Institutional Review Board.

Sample size

Assuming a change in VO2max of 3.5 mL/kg/min to be clinically relevant, α = 0.05, 1-β = 0.80, an expected dropout of 15% for 12 weeks, and a chosen medium effect size of 0.25 due to gaps in the literature, the calculations yielded a total minimum of 48 participants (16 per group) (G\*Power, version 3.1.9.4), however, the sample size will be updated, if necessary, after a pilot study consisting of 12 participants, 4 per group, (48x0.25=12).

Recruitment

Recruitment will be performed mainly at the Coronary Club of Lisbon (CORLIS) (phase III) at the Faculty of Human Kinetics and at the Hospital of Santa Cruz in Lisbon.

Measurements

All study measurements will be collected at the Faculty of Human Kinetics, University of Lisbon. Assessments of cardiopulmonary exercise test (CPET), cardiovagal modulation, body composition, and arterial stiffness, will be conducted both at baseline and after the 12-week intervention period. Participants will be requested to be fasted (\> 4h), abstain from foods/drinks containing caffeine and alcohol (\> 12h), and refrain from strenuous exercise (\> 24h) before assessments, post-intervention assessments will be scheduled for the same time that baseline. The measures will follow the following order body composition, cardiovagal modulation (and baroreflex sensitivity), local and regional arterial stiffness, cardiopulmonary test, and post-maximal exercise cardiovagal modulation (and baroreflex sensitivity), and local and regional arterial stiffness.

Randomization

Baseline evaluation will be done before randomization, thus neither participants nor fieldwork staff will know the group assignment at this point. Due to the nature of the intervention, it will not be possible to blind participants after baseline assessments. After the baseline assessments, block randomization by group with balanced blocks of 12 participants will be performed by a researcher not involved in recruitment or data collection using REDCap (https://imm.medicina.ulisboa.pt/group/redcap/redcap_v7.6.7/). The participants will be randomly allocated to one of the three groups: HIIT, MICT, and HRV-guided training.

Exercise intervention

Exercise intervention will have a 12-week duration, with 3 sessions per week on non-consecutive days for all 3 groups and will be carried out at the Faculdade de Motricidade Humana. Certified exercise physiologists will supervise sessions. Heart rate will be monitored during all sessions with an HR monitor (S810i Polar, Polar Electro, Kempele, Finland; sampling rate 1000 Hz). All sessions will include a 10-minute warm-up, an aerobic component, a strength component, and a cool-down for both groups. The warm-up will focus on increasing HR, improving mobility, and performing preparatory stretches for the conditioning component. The strength component will consist of 6 arm and 2 leg machines with 2 sets of 8 to 12 reps at 50-60% 1RM per machine. The cool-down will transition from the conditioning component to the stretching phase, consisting of static and dynamic stretching exercises for all major muscle groups. Warm-up, strength component and coold-down will be standardized for the 3 groups. Sessions will be deemed completed when at least 83.3% (30 out of 36 sessions i.e. minimum adherence = 83.3%) of the prescribed exercise sessions have been successfully performed (reached the programmed intensity). The aerobic component in all groups will follow linear periodization. Volume and/or intensity will increase every 4 weeks.

Data analysis

All HRV analyses will be performed offline using the FisioSinal software built-in Matlab \[25\]. Time-domain and spectral power analyses will be conducted using 2-min time bins. Ectopic heartbeats (M = 1, SD = 4 b.min-1) will be excluded from the final analysis. The time-domain statistics used to characterize HRV will be SDNN and RMSSD. Non-linear time-domain parameters will be derived from the Poincaré plot including SD1 and SD2. The time-frequency domain analysis will be conducted using the Daubechy-12 discrete wavelet algorithm. Wavelet analysis will be chosen instead of fast Fourier transform as it is better suited to characterize the acute responses of the autonomic nervous system during exercise. The baroreflex effectiveness index (BEI) and BRS will be estimated using the spontaneous sequence method. Briefly, the method casts about adjacent oscillations (ramps) in systolic blood pressure (SBP; \> 1 mmHg) and RR and ( \> 4 ms). BRS will be defined as the average of the BRS slopes. BEI will be calculated as the total number of BRS events divided by the total number of BP ramps observed during the 2-minute time-bin.

Statistical methods

Statistical tests will be performed in R (R studio Version 4.2.2). Descriptive statistics will be employed to analyze demographic and clinical variables measured at the baseline for each group. Categorical variables will be presented using frequencies and percentages, while continuous variables will be expressed as mean ± standard deviation (or median and range).

For the primary and secondary outcomes, data will undergo analysis using linear mixed models in R, and lme4. The fixed effects will be defined as the moment of intervention, and group, and the random intercept will be defined as each participant. Parameter estimation will utilize restricted maximal likelihood and the Kenward-Roger approximation for degrees of freedom will be applied for evaluating significance, ensuring optimal type I error rates. Secondary analyses will explore adjustments for protocol deviations through a per-protocol analysis. Post a significant interaction, pairwise comparisons will be conducted with a Bonferroni adjustment. For main and interaction effects, partial eta squared (η2) will be computed as an effect size estimate. Effect sizes for pairwise comparisons will be reported as Cohen's d, complemented by 95% confidence intervals for mean differences. All statistical analyses will be conducted using R software, with a significant level of α = 0.05.

Study Timeline

• Status Verified: 2025-03
• Study First Submitted: 2025-03-30
• Study First Submitted QC: 2025-04-07
• Last Update Submitted: 2025-04-07
• Study First Posted: 2025-04-09
• Last Update Posted: 2025-04-09
• Study Start: 2025-09-01
• Primary Completion: 2027-12-01
• Study Completion: 2028-06-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• aged over 18 years;
• had angiographically documented CAD in at least one major epicardial vessel;
• clinical evidence of CAD in the form of previous myocardial infarction;
• clinical evidence of CAD in the form of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention);
• clinical evidence of CAD in the form of angina pectoris.

Exclusion Criteria

• heart failure;
• cardiac implantable defibrillators;
• resynchronizing devices;
• inability to comply with guidelines for participation in exercise testing and training.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Cardiovagal modulation	pre and post intervention (12 weeks) assessments	The R-R intervals will be derived from beat-to-beat blood pressure pulse intervals using finger plethysmography (Finapres Nova, Amsterdam, Netherlands), during all measures. Finger plethysmography-derived peak-to-peak intervals are highly correlated with electrocardiogram R-R intervals, with similar variability. The upstroke is determined using the pressure signal with a resolution of 2 ms, and the interval between the two consecutive upstrokes is measured. In the frequency domain, the two primary components are low-frequency (LF: 0.04-0.15 Hz) and high-frequency (HF: 0.15-0.40 Hz) spectra. Heart rate variability measures provide information primarily on vagal modulation with the LF power spectrum reflecting both sympathetic and parasympathetic modulation and HF reflecting the parasympathetic modulation of the R-R intervals. The LF/HF ratio is used as an indicator of sympathovagal dominance.
Cardiorespiratory fitness	pre and post intervention (12 weeks) assessments	An incremental CPET will be performed on a treadmill (Pulsar 3p, HP Cosmos) with mixing-chamber gas exchange measurements (Quark RMR w/CPET, Italy), according to Bruce modified protocol. A 12-lead electrocardiogram will be continuously monitored, and blood pressure will be assessed by auscultation using an aneroid sphygmomanometer. A cardiologist and an exercise physiologist will supervise the CPET.; Before each test, the gas analyzer will be calibrated using ambient air standard calibration gases of known concentrations (16,7% O2 and 5,7% CO2). The turbine flowmeter of Cosmed will be calibrated with a 3L syringe. Data will be analyzed in 20 s average, and peak VO2 will be defined as the highest value attained in the last minute of effort

Secondary Outcome Measures

Name	Time	Method
Local arterial stiffness	pre and post intervention (12 weeks) assessments	Carotid arterial stiffness indices will be assessed using eTRACKING technology (Arietta V60, Hitachi Aloka Medical Ltd, Mitaka-shi, Tokyo, Japan), using a 7.5 MHz linear array probe incorporating a 5 MHz Doppler transducer. In longitudinal view, the probe will be manipulated so that the intima of the artery is imaged clearly from both the anterior and posterior walls and a single scan line is aligned perpendicularly to the vessel walls at a site 20 mm proximal to the carotid bulb. On-screen cursors will be placed on the anterior and posterior intima-media borders to enable tracking of both walls. The corresponding displacement waveforms and diameter curve will be calculated using high-resolution online wall tracking ("E-track" technology), with a sampling rate of 1 kHz. Arterial pressure waveforms were obtained automatically in real-time by calibrating peak and bottom values with SBP and DBP measured with sphygmomanometry, as previously validated.
Regional Arterial Stiffness	pre and post intervention (12 weeks) assessments	Carotid femoral PWV, carotid-radial PWV, and femoral dorsalis PWV will be measured using a non-invasive automatic device (Complior, Alam Medical, France) with participants lied supine on a cushioned table. The common carotid artery, femoral, radial and dorsalis artery pressure waveforms will be recorded using 4 piezoelectric pressure mechanotransducers placed on each artery. The travel time distance will be defined as the tape measured distance over the body surface between the 2 recording sites of interest with distance being corrected by 0.8 factor for carotid femoral. All measurements will be performed by the same operator on the right side of the body after 10 pulse waveforms of enough quality (\> 90%).
Baroreflex sensitivity	pre and post intervention (12 weeks) assessments	Spontaneous sequence method will be used to estimate BRS through the baroreflex module of FisioSinal \[25\]. This method emits about adjacent oscillations (ramps) in R-R and ( \> 4 ms) and systolic blood pressure (SBP) (SBP; \> 1 mmHg). Beat-to-beat SBP will be recorded using finger plethysmography (Finapres Measurement Systems, Amsterdam, Netherlands). A BRS event was defined as the overlap of BP ramps with concordant changes in R-R intervals. Hence, BRS will be defined as the average of the BRS slopes.

Trial Locations

Locations (1)

Faculdade de Motricidade Humana; 🇵🇹 Lisboa, Portugal